Literature DB >> 23509936

Challenging the two-minute tidal breathing challenge test.

Anne J Lexmond1, Paul Hagedoorn, Henderik W Frijlink, Anne H de Boer.   

Abstract

BACKGROUND: In the adenosine 5'-monophosphate (AMP) bronchial challenge test, AMP is usually administered according to dosing protocols for methacholine. We investigated whether the 2-min tidal breathing challenge test for methacholine is applicable to AMP. Parameters known to affect nebulizer output were studied. Our aim was to determine whether control of additional parameters is needed for currently standardized protocols.
METHODS: The study was performed with the Sidestream nebulizer from the APS Pro Aerosol Provocation System (CareFusion Respiratory). The effects of AMP concentration, jet pressure, and suction flow rate on nebulizer output rate and aerosol droplet size distribution were determined.
RESULTS: The volume median diameter for water increased from 5.10 μm to 8.49 μm when the jet pressure was reduced to obtain the prescribed output rate of 0.13 mL/min. The output rate was increased when a suction flow rate was used to remove the aerosol. Increasing the AMP concentration resulted in smaller droplets and a lower output rate when a suction flow was applied.
CONCLUSIONS: The effects of AMP concentration on nebulizer performance may result in changes in the administered dose and site of deposition of AMP at dose escalation. All of the investigated parameters influence nebulizer performance, hence the outcome of a bronchial challenge test. Therefore, these parameters should not only be specified in challenge testing, but be actively controlled as well.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23509936     DOI: 10.1089/jamp.2012.1021

Source DB:  PubMed          Journal:  J Aerosol Med Pulm Drug Deliv        ISSN: 1941-2711            Impact factor:   2.849


  3 in total

1.  A novel method for studying airway hyperresponsiveness in allergic guinea pigs in vivo using the PreciseInhale system for delivery of dry powder aerosols.

Authors:  A J Lexmond; S Keir; W Terakosolphan; C P Page; B Forbes
Journal:  Drug Deliv Transl Res       Date:  2018-06       Impact factor: 4.617

2.  Associations of AMP and adenosine induced dyspnea sensation to large and small airways dysfunction in asthma.

Authors:  Claire A Cox; Ilse M Boudewijn; Sebastiaan J Vroegop; Siebrig Schokker; Anne J Lexmond; Henderik W Frijlink; Paul Hagedoorn; Judith M Vonk; Martijn P Farenhorst; Nick H T Ten Hacken; Huib A M Kerstjens; Maarten van den Berge
Journal:  BMC Pulm Med       Date:  2019-01-28       Impact factor: 3.317

3.  Targeting the small airways with dry powder adenosine: a challenging concept.

Authors:  Erica van der Wiel; Anne J Lexmond; Maarten van den Berge; Dirkje S Postma; Paul Hagedoorn; Henderik W Frijlink; Martijn P Farenhorst; Anne H de Boer; Nick H T Ten Hacken
Journal:  Eur Clin Respir J       Date:  2017-09-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.